Definitive Contract HHSO100201500022C
Award Date 9/30/15
Potential Completion Date 11/30/23
Potential Value $41M
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chelmsford, MA 01824, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $12.051 million definitive contract to Inbios International Inc., a minority-owned biotechnology company, for development of a point-of-care immunoassay for diagnosis of inhalational anthrax on September 26, 2017. The contract carries no set-aside. Place of performance is Seattle, WA. Work extends through September 30, 2027 under cost-plus-fixed-fee pricing. In fiscal year...
- This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to SRI International, a non-profit research and development institute, for the development of a rapid point-of-care anthrax diagnostic assay system. The contract has a ceiling value of $19,765,032.63 and is a cost-plus-fixed-fee definitive contract. It does not utilize any set-aside designations. SRI International has subcontracted with various entities to support different aspects of...
- <p>This is a Cost Plus Fixed Fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Altimmune, Inc. for the development of a single-dose intranasal vaccine for post-exposure prophylaxis of inhalation anthrax. The award has a ceiling value of $135,880,962.00 and a period of performance through December 31, 2021. The contract was awarded on July 27, 2016 and does not have a set-aside designation.</p>
- This is a firm fixed price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract has a ceiling value of $17,254.06 and an ultimate completion date of April 22, 2024. The contract provides medical supplies, with no set-aside designation. Biofire Defense has received prior federal contracts and grants, including a $6.2 million...
- This is a $600,250.78 firm fixed price definitive contract awarded by the U.S. Army Contracting Command - Warren (ACC Warren) to ANP Technologies Inc., a minority-owned, for-profit business focused on nanobiotechnology and diagnostic products. The contract is for the delivery of Handheld Assay Systems (HHAS) with a completion date of February 12, 2022. This award does not have a set-aside designation. ANP Technologies has provided COVID-19 test kits and supplies, as well as other biological...
- This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...
- This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Orasure Technologies Inc. is valued at $710,310 to support the development of a rapid antigen test for COVID-19. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002 and will deliver research and development efforts towards a host-directed therapeutic to aid long-term outcomes from lung...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian federal agency, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract, valued at $12,694.53, is for the delivery of medical supplies with a completion date of February 3, 2024. There is no set-aside designation noted. Biofire Defense LLC has previously received other federal contract and grant awards, including...
- This federal contract award is for the procurement of medical supplies by the Bureau of Administration, a civilian agency of the U.S. government. The contract was awarded to Biofire Defense LLC, a for-profit limited liability company that specializes in biological threat detection and infectious disease diagnostics, on a firm fixed-price basis. The contract has a ceiling value of $25,000.00 and an ultimate completion date of February 3, 2024. There is no set-aside designation for this...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to ANP Technologies Inc., a minority-owned for-profit small business located in Newark, Delaware. The $1,599,533 firm-fixed-price contract will develop rapid, heat-stable handheld lateral flow immunoassays utilizing thermally stable recombinant proteins and nano-intelligent detection system technology to quickly detect various biological targets....